Literature DB >> 15258000

Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996.

Katherine L O'Brien1, Jana Shaw, Robert Weatherholtz, Raymond Reid, James Watt, Janne Croll, Ron Dagan, Alan J Parkinson, Mathuram Santosham.   

Abstract

Streptococcus pneumoniae is the most common cause of invasive bacterial disease among children worldwide. The authors aimed to determine the incidence, clinical characteristics, and serotype distribution of invasive pneumococcal disease (IPD) among Navajo children in the southwestern United States. Active population-based laboratory surveillance for IPD among resident members of the Navajo Nation under 18 years of age was conducted between 1989 and 1996. During this 8-year period, 706 cases of IPD were identified. The rate of disease varied by age, with the highest rate being observed among children aged 6-11 months (727 cases/100,000 person-years), followed by children aged 0-11 months, 0-23 months, and 0-59 months (568, 537, and 272 cases/100,000 person-years, respectively). Among children aged 0-23 months, 60.3% of cases were caused by serotypes in the seven-valent conjugate pneumococcal vaccine (71.5% from 1989-1993 and 58.3% from 1994-1996). Navajo children are at increased risk of IPD in comparison with the general US population. The distribution of disease-causing serotypes is similar to that of many countries in the developing world. Prevention strategies should include the use of licensed pneumococcal protein conjugate vaccine; however, a substantial proportion of disease is caused by nonvaccine serotypes. These data are critical for assessing the impact of these vaccines in this high-risk population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258000     DOI: 10.1093/aje/kwh191

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Pneumonia and influenza mortality among American Indian and Alaska Native people, 1990-2009.

Authors:  Amy V Groom; Thomas W Hennessy; Rosalyn J Singleton; Jay C Butler; Stephen Holve; James E Cheek
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

2.  Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities.

Authors:  Jennifer R Scott; Eugene V Millar; Marc Lipsitch; Lawrence H Moulton; Robert Weatherholtz; Mindy J Perilla; Delois M Jackson; Bernard Beall; Mariddie J Craig; Raymond Reid; Mathuram Santosham; Katherine L O'Brien
Journal:  J Infect Dis       Date:  2011-11-29       Impact factor: 5.226

3.  A prospective study of agents associated with acute respiratory infection among young American Indian children.

Authors:  Niranjan Bhat; Rafal Tokarz; Komal Jain; Saddef Haq; Robert Weatherholtz; Aruna Chandran; Ruth Karron; Raymond Reid; Mathuram Santosham; Katherine L O'Brien; W Ian Lipkin
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

4.  Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.

Authors:  Eiman M Mokaddas; Vincent O Rotimi; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

Review 5.  Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.

Authors:  Cynthia G Whitney; David Goldblatt; Katherine L O'Brien
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

6.  Low child survival index in a multi-dimensionally poor Amerindian population in Venezuela.

Authors:  Julian A Villalba; Yushi Liu; Mauyuri K Alvarez; Luisana Calderon; Merari Canache; Gaudymar Cardenas; Berenice Del Nogal; Howard E Takiff; Jacobus H De Waard
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005.

Authors:  Michael G Bruce; Shelley L Deeks; Tammy Zulz; Dana Bruden; Christine Navarro; Marguerite Lovgren; Louise Jette; Karl Kristinsson; Gudrun Sigmundsdottir; Knud Brinkløv Jensen; Oistein Lovoll; J Pekka Nuorti; Elja Herva; Anders Nystedt; Anders Sjostedt; Anders Koch; Thomas W Hennessy; Alan J Parkinson
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

8.  Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.

Authors:  Lindsay R Grant; Sarah E O'Brien; Polly Burbidge; Mitch Haston; Marta Zancolli; Lucy Cowell; Marina Johnson; Robert C Weatherholtz; Raymond Reid; Mathuram Santosham; Katherine L O'Brien; David Goldblatt
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

Review 9.  The changing epidemiology of childhood pneumococcal disease in Korea.

Authors:  Young June Choe; Eun Hwa Choi; Hoan Jong Lee
Journal:  Infect Chemother       Date:  2013-06-26

10.  Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea.

Authors:  Xu-Hao Zhang; Oscar Leeuwenkamp; Kyu-Bin Oh; Young Eun Lee; Chul-Min Kim
Journal:  Hum Vaccin Immunother       Date:  2017-11-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.